Thursday, June 25, 2020 6:59:07 PM
Sorry have not been around. Yes, that's what I have been hearing around here in the True North and strong....land of snow (lot's of it too). The data should be out soon, I am thinking before end of net week. The only thing is they may want to delay it by a week to get through Canada Day July 1 and July 4th holidays. The functional data is what this a very exciting play. The dips were nice for some to pick up. Cormack (brokerage) was buying up everything or most of the shares this past week. Everyone, waiting for the data anxiously. I think the data will be good since they already have a couple of collaboration types of agreements already. Connected to major Pharma with IPA will see great upside. Hold tight!!!
Recent IPA News
- ImmunoPrecise Antibodies (IPA) publie ses résultats financiers et les faits saillants de ses activités du premier trimestre de l’exercice 2025 • Business Wire • 09/17/2024 02:13:00 AM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 09/16/2024 08:01:33 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/16/2024 01:04:43 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/16/2024 01:03:19 PM
- ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 • Business Wire • 09/16/2024 01:00:00 PM
- U.S. Markets Await Fed Decision and Empire State Report Amid Global Economic Shifts; Oil Prices Rise Slightly • IH Market News • 09/16/2024 10:04:55 AM
- IPA publiera le 16 septembre 2024 ses résultats financiers et les récents faits saillants de ses activités du premier trimestre de l’exercice 2024 • Business Wire • 09/09/2024 09:44:00 PM
- IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024 • Business Wire • 09/09/2024 01:11:00 PM
- L'IPA participera à la 26e conférence annuelle mondiale de l'investissement organisée par H.C. Wainwright à New York • Business Wire • 08/26/2024 04:12:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/26/2024 01:41:08 PM
- ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York • Business Wire • 08/26/2024 01:00:00 PM
- ImmunoPrecise Antibodies reçoit un avis de la part du Nasdaq concernant les exigences minimales en matière d'offre • Business Wire • 08/24/2024 07:35:00 AM
- ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements • Business Wire • 08/24/2024 12:00:00 AM
- ImmunoPrecise Antibodies conçoit des anticorps in silico pour des protéines tumorales élusives en utilisant sa technologie LENSai brevetée • Business Wire • 08/19/2024 06:04:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/19/2024 01:21:46 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/19/2024 04:15:03 AM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 08/06/2024 09:16:28 PM
- ImmunoPrecise Antibodies (IPA) publie ses résultats financiers et ses mises à jour commerciales pour le quatrième trimestre et l'exercice 2024 • Business Wire • 07/30/2024 01:05:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/29/2024 12:38:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/29/2024 12:35:02 PM
- ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024 • Business Wire • 07/29/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/24/2024 01:55:46 AM
- ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024 • Business Wire • 07/23/2024 11:30:00 PM
- ImmunoPrecise annonce un accord de financement avec Yorkville Advisors Global, LP d'un montant en capital global de 3,0 millions USD de débentures convertibles • Business Wire • 07/17/2024 12:22:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM